References
- Aberle DR, Adams AM, Berg CD, et al., 2011. Reduced lung cancer mortality with low-dose computed tomography screening. N Engl J Med, 365395-409.
- Aird I, Bentall HH, Roberts JA (1953). A relationship between cancer of stomach and the abo blood groups. Br J Med J, 1, 799-801. https://doi.org/10.1136/bmj.1.4814.799
- Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al., 2009. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet, 41, 986-90. https://doi.org/10.1038/ng.429
- Ashley DJB (1969). Blood groups and lung cancer. J Med Genet, 6, 183-6. https://doi.org/10.1136/jmg.6.2.183
- Dall’olio F (1996). Protein glycosylation in cancer biology: An overview. Clin Mol Pathol, 49, 126-35. https://doi.org/10.1136/mp.49.3.M126
- Edgren G, Hjalgrim H, Rostgaard K, et al., 2010. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol, 172, 1280-5. https://doi.org/10.1093/aje/kwq299
- Finkelstein DM, Ettinger DS, Ruckdeschel JC (1986). Long-term survivors in metastatic non-small cell lung cancer: an Eastern Cooperative Oncology Group Study. J Clin Oncol, 4, 702-9.
- Graziano SL, Tatum AH, Gonchoroff NJ., 1997. Blood group antigen A and flow cytometric analysis in resected early stage non-small cell lung cancer. Clin Cancer Res, 3, 87-93.
- Greer JB, Yazer MH, Raval JS, et al., 2010. Significant association between abo blood group and pancreatic cancer. World J Gastroenterol, 16, 5588-91. https://doi.org/10.3748/wjg.v16.i44.5588
- Hosoi E (2008). Biological and clinical aspects of ABO blood group system. J Med Invest, 55, 174-82. https://doi.org/10.2152/jmi.55.174
- Iodice S, Maisonneuve P, Botteri E., 2010. AB0 blood group and cancer. Eur J Cancer, 46, 3345-50. https://doi.org/10.1016/j.ejca.2010.08.009
- Landsteiner K (1900). Zur Kenntnis der antifermentativen, lytischen and agglutinierenden Wirkungen des Blutserums und der Lymphe. Zentralbl Bakteriol, 27, 357-62.
- Lee JS, Ro JY, Sahin AA, et al (1991). Expression of blood group antigen A: a favourable prognostic factor in non-small cell lung cancer. N Engl J Med, 324, 1084-90. https://doi.org/10.1056/NEJM199104183241603
- Lee JS, Hong WK (1992). Prognostic factors in lung cancer. N Engl J Med, 327,47-8. https://doi.org/10.1056/NEJM199207023270110
- Miyake M, Taki T, Hitomi S., 1992. Correlation of expression of H/Ley/Leb antigens with survival in patients with carcinoma of the lung. N Engl J Med, 327, 14-8. https://doi.org/10.1056/NEJM199207023270103
- Reid ME, Mohandas N (2004). Red blood cell blood group antigens: structure and function. Semin Hematol, 41, 93-117.
- Roberts TE, Hasleton P, Swindell R., 1988. Blood groups and lung cancer. Br J Cancer, 58, 278. https://doi.org/10.1038/bjc.1988.201
- Siegel R, Ward E, Brawley O., 2011. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 212-36.
- Suadicani P, Hein HO, Gyntelberg F (2007). ABO phenotypes and inflammation related predictors of lung cancer mortality: the Copenhagen Male Study-a-16 year follow up. Eur Respir J, 30, 13-20. https://doi.org/10.1183/09031936.00062506
- Urun Y, Utkan G, Yalcin S, et al., 2012. Lack of any relationship between ABO and Rh blood groups and clinicopathological features in patients with gastrointestinal tromal tumors: Turkish Oncology Group. Asian Pac J Cancer Prev,13, 4129-31. https://doi.org/10.7314/APJCP.2012.13.8.4129
- Wolpin BM, Chan AT, Hartge P, et al., 2009. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 101, 424-31. https://doi.org/10.1093/jnci/djp020
- Wolpin BM, Kraft P, Gross M, et al., 2010. Pancreatic cancer risk and ABO blood group alleles: Results from the Pancreatic Cancer Cohort Consortium. Cancer Res, 70, 1015-23. https://doi.org/10.1158/0008-5472.CAN-09-2993
- Zmijewski CM (1978). Immunohematology 3rd ed.: Appleton Century Crofts New York.
Cited by
- Does Sunlight Exposure Improve Survival in Patients with Non-small Cell Lung Cancer? vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6301
- Serum IL-33 as a Diagnostic and Prognostic Marker in Non-small Cell Lung Cancer vol.14, pp.4, 2013, https://doi.org/10.7314/APJCP.2013.14.4.2563
- ABO Blood Groups are Not Associated with Treatment Response and Prognosis in Patients with Local Advanced Non-Small Cell Lung Cancer vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3945
- Clinical Observations on the Association Between Diagnosis of Lung Cancer and Serum Tumor Markers in Combination vol.14, pp.7, 2013, https://doi.org/10.7314/APJCP.2013.14.7.4369
- Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution in Turkey vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6263
- Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer vol.19, pp.4, 2014, https://doi.org/10.3109/1354750X.2014.908954
- The diagnostic and prognostic value of serum human kallikrein-related peptidases 11 in non-small cell lung cancer vol.35, pp.6, 2014, https://doi.org/10.1007/s13277-014-1674-x
- Hemostasis, cancer, and ABO blood group: the most recent evidence of association vol.38, pp.2, 2014, https://doi.org/10.1007/s11239-013-1027-4
- Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4891
- Rhesus CE expression on patient red blood cells is an independent prognostic factor for adenocarcinoma of the lung pp.17526981, 2018, https://doi.org/10.1111/crj.12638
- Association of ABO blood groups with von Willebrand factor, factor VIII and ADAMTS-13 in patients with lung cancer vol.14, pp.3, 2017, https://doi.org/10.3892/ol.2017.6619
- The Prevalence of Rhesus-Negative Blood Group Among Patient With Small Cell Lung Cancer and Analysis of Its Effect on Overall Survival vol.8, pp.2234-943X, 2018, https://doi.org/10.3389/fonc.2018.00358